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Rates of bone loss in young adult males
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Abstract
Osteoporosis-related fractures occur more frequently in women compared with men, but mortality
is greater in men compared with women. Peak bone mass is a significant predictor of osteoporosis
and fracture risk; therefore, it is important to optimize peak bone mass during young adulthood.
Several recent longitudinal studies, which are summarized in this article, have investigated bone
changes among young men. Cortical bone loss does not appear to be significant until individuals
reach their mid-30s and is associated with decreased sex hormone concentrations. Significant
trabecular bone loss in young men aged in their 20s has been reported and is associated with reduced
lean mass and activity levels, especially among former athletes. Whether changes in activity levels
among nonathletes lead to bone loss among young men requires further investigation.
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Epidemiology
Osteoporosis is an important disease affecting approximately 75 million people in Europe, the
USA and Japan [1]. In 2000, there were an estimated 9 million new osteoporotic fractures
worldwide, with approximately 1.7 million forearm fractures, 1.6 million hip fractures and 1.4
million vertebral fractures [2]. Although osteoporosis and osteoporosis-related fractures occur
more frequently in women, with a female-to-male ratio of 1.6 [2], the estimated lifetime risk
of an osteoporotic fracture in men over the age of 50 years is substantial at 30%. Increased
mortality risk 5–10 years following a low trauma fracture has also been observed in both older
Australian men and women [3]. Although the prevalence of osteoporotic fractures is lower in
Australian men than in Australian women, the overall fracture-related mortality is greater in
men aged 60 years and older, with a 20% mortality in the first 12 months following a hip
fracture [4]. These data emphasize the importance and significance of understanding factors
associated with bone gain and later bone loss in men.
Peak bone mass is thought to be a significant predictor of future osteoporosis and fracture risk.
This is based on studies that have demonstrated that dual energy x-ray absorptiometry (DXA)
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measures of bone mineral density (BMD) are associated with future fracture risk [5], and that
BMD tracks within an individual both in childhood [6] and adulthood [7]. Low BMD is also
an important determinant of current fracture risk. In a longitudinal study of 2179 Canadian
men aged 50–90 years, over 50% of those who experienced low-trauma fractures had
osteopenia, and the incidence of repeat fractures was approximately doubled in the men with
osteopenia [8].
Bone as a tissue
Bone is generally classified into two types: trabecular and cortical bone. Cortical bone (also
known as compact bone) is less porous than trabecular bone and is found primarily in the shaft
of long bones, in the outer shell surrounding trabecular bone at the end of long bones and at
the vertebrae. Trabecular bone (also known as spongy bone) is more porous and is found at
the end of long bones, in vertebrae and in flat bones such as the pelvis.
Most longitudinal bone growth ceases by the end of puberty and is thought to be a result, in
both males and females, of the actions of increased pubertal estrogen concentrations to induce
epiphyseal maturation and closure [9–11]. By the late teens, longitudinal bone growth is
negligible in most individuals, although growth in bone width continues through bone
modeling and periosteal expansion. Bone modeling involves osteoblasts depositing bone
matrix and later mineralizing it on the periosteal surface, while osteoclasts resorb bone on the
endosteal surface [12]. Modeling leads to expansion of the periosteal surface and an increase
in the size of the marrow cavity. Bone remodeling also occurs through successive cycles of
bone resorption and bone formation, but this process occurs along the same bone surface with
osteoclast-mediated resorption of bone and subsequent osteoblast-mediated laying down of
new bone. Usually, bone removal and addition are closely balanced so that there is little to no
net effect on the total amount of bone. However, the remodeling process is important for
repairing microfractures and allowing for dynamic adaptation to variable external stresses.
Methods for assessing bone
The strength of bone is a function of both bone shape or architecture and bone density. Density
is the mass of an object divided by its volume. In standard bone nomenclature, the term ‘bone
density’ usually refers to the degree to which a radiation beam is attenuated by a bone. DXA
is the most widely used densitometric method for diagnosing osteoporosis; advantages of DXA
are its wide availability, relatively low radiation exposure and short scanning times. However,
bone measures by DXA are only in 2D and they provide estimates of the amount of bone
mineral content (BMC) and bone area within a specific region or in the total body. BMD is
then calculated as BMC/bone area (g/cm2). Because this is a 2D measurement, and not an
actual volumetric measurement, DXA results are often referred to as areal BMD (aBMD).
aBMD measurements are influenced by bone size; larger bones will by definition have greater
aBMD even though the actual volumetric (3D) density is the same [13]. This presents problems
when interpreting aBMD differences within and across different ages and sexes.
Quantitative computed tomography (QCT) provides a 3D assessment of bone size and
geometry and permits analysis of cortical and trabecular BMD (volumetric BMD [vBMD]).
In addition, specific geometric parameters of cortical bone can be derived from cross-sectional
images (e.g., periosteal and endosteal circumferences, cortical thickness and cortical area)
(Figure 1). Cortical vBMD measured by QCT methods is an integrated measure of both the
material density of the cortical bone itself, as well as the cortical porosity. Increased cortical
porosity is seen during periods of high bone turnover. Although studies show that aBMD
measured by DXA is greater in males than females, studies using QCT or peripheral QCT
(pQCT) indicate that cortical vBMD is actually higher in females than males following puberty
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and up until the time of menopause [14,15]. Most studies suggest that the overall actions of
estrogen are to decrease bone turnover [15], thereby explaining the higher cortical vBMD in
women than men during the reproductive years.
Longitudinal adult studies have shown aBMD by DXA to predict future fracture risk [16,17],
although the sensitivity for assessing vertebral fracture risk is relatively low (65% using WHO
criteria) [18]. Criteria for diagnosing osteoporosis are based on the aBMD T-score, which is
defined as the observed aBMD expressed in standard deviation (SD) units based on the mean
and SD of a normal young adult. A T score of less than −1 SD defines osteopenia and a T score
of less than or equal to −2.5 SD defines osteoporosis [19]. Although aBMD results from
regional spine and hip DXA scans predict future fracture risk and are usually the primary
outcomes reported in studies, they are not as informative for assessing bone structure or
assessing cortical and trabecular vBMD. Bone size and geometry, both of which are known to
significantly influence bone strength [20], can be measured using QCT.
Role of androgen & estrogen on bone in young adult men
The notion that osteoporosis would be expected to be a disease affecting a significant
percentage of men is increasingly accepted. This is due not only to the obvious impact of
disease-related androgen deficiency on the male skeleton, but also due to recent studies
demonstrating the effect of waning androgen sufficiency on aging male bone [21]. Estrogen,
which has been known to influence female bone health for decades, has also recently been
shown to be important in growing and aging males for bone growth and metabolism [9,22,
23]. In males, unlike females where the ovaries are the primary source of estrogen, the majority
of the estrogen in the circulation is derived from the peripheral aromatization of testicular-
derived androgens by the cytochrome P450 enzyme, aromatase [24]. Studies of individuals
with androgen insensitivity support the role of androgens on maintaining trabecular bone
[25], and androgen receptors have been reported in human osteoblasts [26]. The importance
of estrogen for normal bone mineralization in the male skeleton is particularly supported by
reports of markedly decreased spine aBMD in aromatase-deficient men and their dramatic
improvement within 6 months of estrogen treatment [23,27–32]. Similarly, histomorphometric
analysis of a man with an estrogen receptor-α point mutation (hERKO) revealed decreased
trabecular thickness and volume, but a preservation of trabecular number [33]. DXA measures
of the spine aBMD were profoundly low with a Z score of −3.9. pQCT measures of the radius
showed normal periosteal circumference coupled with greater endosteal circumference
resulting in a smaller cortical thickness compared with controls. Both decreased trabecular and
cortical vBMD were also observed. Interestingly, Rochira and coworkers found a significant
increase in spine aBMD following androgen administration of an aromatase-deficient man who
had been receiving estrogen replacement for approximately 2 years [34]. A clear consensus is
emerging from these studies that androgen and estrogen individually, and in a complex
collaborative manner, act to promote healthy bone growth and mineralization.
Role of body composition on bone in adolescent & young adult men
Weight and height are significantly associated with bone measures, part of which is a reflection
of differences in bone size [13,35]. However, it is becoming increasingly clear that the amount
of both lean and fat mass, as well as total body mass, has an important influence on bone. The
data on the relationship between bone and lean mass is quite consistent and indicates that bone
outcomes are positively associated with lean mass [36–42]. By contrast, the association
between bone outcomes and fat mass, if any, is not clear. Whether the relationship between
bone and lean mass is due to genetic factors influencing body size or an indirect measure of
the influence of bone-loading activities on bone is not known.
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A popular analytical approach to investigate the role of fat mass has been to directly relate
bone outcomes to fat mass and other covariates using multivariate regression models. Use of
this type of analysis in cross-sectional studies of children and adolescents has resulted in both
positive and negative associations between fat mass and some bone measures [36–39]. Some
of the studies that included males and found a negative association of fat mass and bone
measures used regression models containing both body weight and fat mass [43,44], which has
been criticized because inclusion of body weight and fat mass in the same model complicates
the interpretation of the regression coefficient for fat mass [45]. However, other studies did
not have this problem and still found negative associations between DXA-measured bone
outcomes and fat mass [40,41]. It has been suggested that detrimental effects of fat mass may
be partly due to displacement of lean mass [36]. In this study, both lean mass and fat mass were
positively associated with bone mass, but the magnitude of the fat mass effect was much less
than the lean mass effect. Thus, an increase in fat mass at a fixed body weight (increase in
percentage fat mass) would attenuate the influence of lean mass and effectively be detrimental
to bone.
A cross-sectional study conducted in twins found that femoral neck BMD was associated with
lean mass independent of fat mass and height. Upon further analyses, these authors concluded
that 60–80% of the individual variances in both femoral neck BMD and lean mass, and greater
than 50% of their covariance, were accounted for by genetic factors. They also speculated that
the relationship between BMD and lean mass was a result of genes that regulated body size,
since the cross-twin correlations between BMD and lean mass were no longer different between
monozygotic and dizygotic twins when height and fat mass were included in the analysis.
There is one cross-sectional study of healthy male siblings (aged 25–45 years) that investigated
the associations of fat mass and lean mass with pQCT-measured bone outcomes for the radius
and tibia [42]. At both the radius and tibia, lean mass was found to be positively associated
with cortical area and periosteal circumference, but negatively associated with cortical vBMD.
By contrast, fat mass was negatively associated with cortical area and periosteal circumference
for radius and tibia, and no significant association with cortical vBMD was observed. Leptin,
which is produced by adipocytes, has been shown in animal models to influence bone mass
both locally (negative association with bone mass) and centrally (positive association with
bone mass) through the hypothalamus [46]. Taes and coworkers found that in multivariate
models with age and height, leptin was negatively associated with cortical bone area and
periosteal circumference at the radius and tibia. When fat mass was added to the statistical
model, the effect of leptin was no longer significant, whereas a negative association with fat
mass remained. These results suggest that leptin is not responsible for the negative association
between bone and fat mass.
Some cross-sectional studies have specifically addressed gender-dependent effects of fat mass
on bone outcomes, and although some differences between males and females are noted, there
are no consistent trends. A problem with comparing results among these studies is the use of
different bone measures. One finding consistent in two studies was a significant negative
association between spine aBMD and fat mass in males, but in females the association was
positive [41] or not significant [40].
As previously noted, the longitudinal study design allows investigation of associations that
reflect relationships within individuals. Changes in a bone measure over time inferred from a
cross-sectional association across individuals of different ages may not accurately reflect what
occurs over time within an individual. Indeed, Clark et al. found positive cross-sectional
associations, as well as negative longitudinal associations, between fat mass and total body
BMC and bone area for young girls that depended on pubertal stage [37]. A small number of
other longitudinal studies of DXA-measured bone accrual during growth suggest that weight
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gain in the form of fat mass has a negative effect on bone geometry [47] and aBMD adjusted
for height [6].
Peak bone mass & subsequent bone loss in young adult men
Approximately 90% of adult bone mass in both sexes is gained in the first two decades of life
and peak bone mass is typically achieved by the early-to-mid 20s. As peak bone mass is a
significant predictor of later osteoporosis and fracture risk, optimizing peak bone mass during
young adulthood is hypothesized to be important in reducing osteoporosis and fractures later
in life.
The National Health and Nutrition Examination Survey (NHANES) III study provides the most
widely used adult male total hip aBMD cross-sectional reference dataset [48]. Based on these
data and other cross-sectional studies, aBMD for the hip and spine peaks during or before 20–
30 years of age, while the whole body and forearm aBMD appears to peak after 30 years of
age [49,50]. The age at which peak vBMD occurs is much younger. Gilsanz and coworkers,
in a cross-sectional study of 150 females aged 2–20 years, found that trabecular vBMD
increased around the age of puberty and remained constant thereafter [51]. Race differences
were not apparent prior to puberty, but following puberty African–American girls had greater
vBMD compared with Caucasian girls.
Longitudinal studies are used over cross-sectional studies when determining age at peak bone
mass. However, these studies are more difficult, and to better define peak bone mass the age
range for such a cohort study would need to span adolescence and early adulthood. A
longitudinal study of bone acquisition in healthy youth of diverse races (Asian, Hispanic, black
and Caucasian) found that increases in aBMD in boys leveled off at approximately 16 years
of age for the total hip and at 18 years for spine and whole body [52]. However, this study
included 193 males aged 8.8–25.9 years at enrollment, but only 12 boys were aged 19 years
or older. The use of a longitudinal study design to define peak bone mass is preferred since
peak bone mass inferred from cross-sectional data may be biased owing to a cohort effect if
there is a secular trend in bone mass.
As individuals age following attainment of peak bone mass there is loss of bone, and attenuating
this age-related reduction in bone is an important strategy for prevention of osteoporosis. The
majority of investigations to estimate rates of bone loss in the period after peak bone mass have
focused on the transition from pre- to post-menopause in women. The majority of studies that
have investigated factors influencing bone loss in adult men use a cross-sectional design. Data
from cross-sectional studies have been shown to both overestimate or underestimate rates of
change observed in longitudinal studies [53,54]. The reason for these discrepancies are
illustrated in Figure 2, which shows the difference in the estimated rate of change based on
cross-sectional (panel A) and longitudinal data (panel B). Regression lines are fitted to cross-
sectional data and the rates of loss estimated based on the regression equation, whereas with
longitudinal data, the actual rates of change are calculated for an individual and the mean rates
of change are then calculated. In this example, the reader would conclude, based on cross-
sectional data, that there is a constant rate of change in aBMD with increasing age, but in
actuality individual rates of change reveal an age-dependent influence on loss of aBMD.
Longitudinal bone changes in young adult men
Another strategy for increasing bone mass in aging men is to increase the peak bone attained
as an adolescent or young adult. Several recent longitudinal studies have investigated bone
change in young men (Table 1). These investigations can be grouped according to their purpose.
Two studies were performed to describe the rates of bone gain or loss [7,54]; two studies
focused on the relationships between the rate of bone gain or loss and sex hormone
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concentrations [55,56]; and several defined the impact of lean mass or physical activity on
rates of bone gain or loss [57–59]. These studies are summarized in Table 1 and described in
detail in the following sections.
Longitudinal bone changes in men
The Tromso Study was a population-based study in Norway that followed men (n = 147, aged
25–44 years at enrollment) for 6.4 years [7]. The subjects were stratified into 25–29, 30–34,
35–39 and 40–44 year age groups and single x-ray absorptiometry was used to measure aBMD
at the distal and ultradistal radius: single x-ray absorptiometry is similar to DXA, but is only
used at peripheral sites, where the soft tissue surrounding the bone is more homogenous. aBMD
of the distal and ultradistal radius were obtained at baseline and at 6.4 years. A significant age
effect on rates of bone change was observed among men with peak aBMD occurring in the
30–34 year age group. Significant aBMD losses at the distal (primarily cortical bone) radius
were observed in both the 35–39 and 40–44 year age groups, while loss at the ultradistal radius
was only significant in the 35–39 year age group.
The InCHIANTI study (Invecchiare in Chianti, aging in the Chianti area) was a population-
based study of Italian men (n = 345) and women (n = 464) aged 21–102 years who were
followed over a 6-year period with tibial pQCT measurements at baseline and at 3 and 6 years
[54]. As shown in Figure 3, younger men had greater rates of loss of trabecular vBMD, but
greater gains in total and cortical bone area than older men. An estimate of the rate of loss of
vBMD in the men aged 20 years was calculated from the regression equation and was 0.6%/
year, similar to the findings of Riggs et al. [56]. The increase in periosteal apposition that was
observed among the young men in this study, as seen by the increase in total bone area, may
explain why others have found decreases in aBMD among young men without an apparent
change in BMC [57]. The increase in bone size, with no change in bone mass, would lead to
a decrease in aBMD. Although a decrease in aBMD may be viewed as an increase in fracture
risk, the larger periosteal circumference would actually lead to a greater cross-sectional
moment of inertia and increased bone strength [60].
Relationship of sex hormones to bone changes in young adult men
Two studies have investigated the relationship between longitudinal bone changes and sex
hormone concentrations among men [55,56]. One of the first studies to report a bone loss in
young men was a population-based study by Khosla and coworkers [55] who studied 346 men
aged 22 years and older (88 were 22–39 years at baseline). Spine, hip and radius aBMD were
measured at baseline and at 2 and 4 years to determine the relationship between longitudinal
bone changes and sex steroid concentrations. They categorized men into 22–39, 40–59 and
over 60 year age groups and found that significant loss in spine aBMD occurred at all ages and
was not associated with estrogen or testosterone concentrations. However, increases in hip and
radius aBMD were observed among the younger men in the 22–39 and 40–59 year age groups,
and greater increases in radius aBMD were observed among men with higher serum estrogen
levels. These results showed the importance of estrogen in increasing radial aBMD in males,
and that losses in spine aBMD are seen in men as young as 22–39 years of age and are not
related to estrogen or testosterone concentrations.
An age-stratified, random, population-based sample of men aged 21–97 years were enrolled
in a prospective study in Rochester, MN, USA [56]. There were 309 men with at least 1, and
up to 3 years of follow-up including pQCT of the radius and tibia, and spiral QCT spine
measurements. Sex steroid concentrations and bone turnover markers, as well as serum IGF-1
and IGFBP-3 concentrations, were measured in fasting blood. Men were categorized into
decade of life and significant decreases in trabecular vBMD at both the ultradistal radius and
spine were observed in all age categories beginning at 30–39 years up to greater than 80 years;
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however, while most age groups had at least 45 men, the 20–29 year age group only had eight
men. Changes in trabecular vBMD were not associated with any of the sex steroid
concentrations. Rates of cortical vBMD loss at the distal radius occurred in men older than 40
years and were associated with bioactive estradiol, testosterone and IGF-I concentrations:
lower rates of bone loss were associated with higher hormone concentrations.
The above studies by Khosla and Riggs focused on whether bone changes in men were
associated with hormonal changes; both studies found a relationship between changes in
cortical bone and estradiol and testosterone concentrations. In addition, both studies reported
early bone loss in trabecular vBMD or bone sites composed of primarily trabecular bone (i.e.,
spine) that was not associated with hormone concentrations. The same rapid bone loss seen in
trabecular bone was not seen in cortical bone or at bone sites composed of primarily cortical
bone (i.e., radius); changes at these cortical bone sites were influenced by sex hormone levels.
Riggs and coworkers concluded by stating that “the early-onset, substantial trabecular bone
loss in both sexes during sex steroid sufficiency is unexplained and indicates that current
paradigms on the pathogenesis of osteoporosis are incomplete [56].
Relationship of lean mass or activity to longitudinal bone changes in young adult men
Animal studies, as well as cross-sectional and longitudinal bone studies among athletes, have
supported the theory that structural adaptations to bone occur with mechanical loading. Bone
marrow fat has been shown to be inversely associated with vertebral vBMD in young adults,
supporting the hypothesis that there may be a common progenitor cell capable of a mutually
exclusive differentiation into cell lineages responsible for fat and bone formation [61]. In
vivo studies found that running rats exhibited a decrease in marrow fat volume and an increase
in bone formation rate compared with sedentary rats [62]. These authors also found in tissue
and cell culture studies that cyclic loading lowered PPAR-γ, which typically has proadipocytic
and antiosteoblastic activity. The results of these studies indicate that mechanical stimuli may
modify the balance between adipogenesis and osteoblastogenesis. Unfortunately, there are no
studies that have investigated longitudinal changes in activity levels, marrow fat and bone
density in young men.
Although some studies suggest that the bone response is greater during growth [63], there is
also evidence that bone-loading activities are important postpuberty [64,65]. Some studies have
reported long-term benefits of early bone loading [66,67], while other studies do not find
persistent skeletal effects [64]. It has become increasingly clear that the response to mechanical
loading is site specific and may differ in trabecular and cortical bone [59,68].
Few studies have measured physical activity levels longitudinally, but insight into the role of
activity on longitudinal bone changes can also be obtained by investigating the relationship
with changes in lean mass, which is considered a surrogate for activity levels. There are several
longitudinal studies on bone changes in young men and the relationship to either changes in
activity levels or lean mass (Table 1).
Bakker and coworkers reported the results of the Amsterdam Growth and Health Longitudinal
Study conducted in The Netherlands [57]. A total of 225 men were enrolled at 13 years of age
and spine bone measurements were made at age 27 (n = 84), 32 (n = 195) and 36 (n = 170)
years. Variables that were considered in their study included weight, height, BMI, skinfold
measurements, body composition variables, and measures of physical activity and calcium
intake. They reported a significant loss in spine aBMD between 27 and 32 years of age. Spine
BMC did not change, suggesting that the loss in aBMD was due to an increase in spine bone
area. Lean mass was the most significant predictor of change in spine aBMD and BMC, with
higher lean mass being associated with greater aBMD and BMC. These investigators found
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that lean mass explained 6% of the variance in spine BMC and 4% of the variance in spine
aBMD.
Nordstrom and coworkers recruited 107 male volunteers from two northern Swedish high
schools and ice hockey and badminton clubs at a mean age of 17 years [58]. They measured
hip, femoral neck and spine aBMD at baseline and at mean ages 19, 23 and 25 years. Although
they found no significant change in spine aBMD, they did observe significant losses in hip and
femoral neck aBMD after 19 years that paralleled losses in BMC. Significant declines in
physical activity levels were also observed, declining from 7.1 to 4.2 h of vigorous activity per
week between 17 and 25 years of age. Men with the larger declines in activity had the greatest
aBMD loss. In a subsequent paper, changes in aBMD were compared among those athletes
who stopped their active careers during follow-up (n = 51), those who continued to be active
throughout the follow-up (n = 16) and 25 controls [59]. As shown in Figure 4, significant
declines in femoral neck aBMD occurred among the former athletes, while active athletes
maintained high aBMD throughout the study compared with controls. Similar results were
observed for spine and total body aBMD. A subsequent follow-up paper presented the results
at 29 years of age and found that over the 12-year follow-up period reduced physical activity
was more strongly associated with changes in trabecular aBMD sites than cortical aBMD sites
[68]. The beneficial effect of high activity levels earlier in life was still apparent at
predominantly cortical bone sites. These authors concluded that conflicting results in the
literature on whether there is a long-term bone benefit of increased activity levels early in life
are probably due to which bone site is studied.
Preliminary results of an ongoing longitudinal 3-year study of bone loss in rural and nonrural
men from South Dakota aged 20–66 years at enrollment were consistent with those described
above, including significant loss in hip aBMD and trabecular vBMD in young men [69]. A
subset of these men were known to play varsity sports (e.g., American football and basketball)
while in college and changes in their hip Z score over the 3-year study are shown in Figure 5
compared with age-matched men whose sport status was unknown. These results are consistent
with Nordstrom et al. [58], indicating that change in activity levels in young men may have a
significant effect on bone changes and may simply reflect a ‘normalization’ of bone to current
loads that are placed upon it.
The importance of lean mass on longitudinal bone changes in young men was seen in the paper
by Bakker et al., which reported lean mass as the most significant predictor of spine aBMD
and BMC change in young men [57]. The influence of lean mass, rather than total body weight,
on bone is probably a reflection of the effect of loading on bone since lean mass theoretically
should be associated with physical activity levels.
There are several cross-sectional and longitudinal studies showing a relationship between bone
and bone-loading activities among male athletes and nonathletes [59,70–72]. However,
longitudinal data on activity levels in young men who are not athletes are scarce. Sport-related
activities have been shown to decrease between 20–29- and 30–39-year-old men [73]. This
decrease in bone-loading activities may be responsible for the rapid bone loss observed at the
hip and femoral neck in some longitudinal studies [58,59], but not others [55].
Both the studies by Bakker et al. [57] and Nordstrom et al. [58] illustrate how changes in lean
mass or activity levels may influence the rate of bone loss in young men. Bakker et al. found
that bone changes were associated with changes in lean mass [57], while Nordstrom’s group
found significant bone loss in former athletes and no bone loss in controls [58,59]. Bakker et
al. found that changes in lean mass influenced changes in spine aBMD, while the studies by
Nordstrom and coworkers found that reduced activity levels were associated with significant
loss at bone sites consisting predominantly of trabecular bone [58,59,68]. Unfortunately, the
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hip was not measured in the study by Bakker and coworkers. In our preliminary data, former
athletes had higher hip Z scores that decreased more significantly over the 3-year follow-up
than the age-matched controls.
Conclusion
Although osteoporosis and osteoporosis-related fractures occur more frequently in women
compared with men, the mortality associated with an osteoporotic fracture is greater in men
than in women. Estrogen, known to influence bone health in women, has also been shown to
be important in males for bone growth and mineralization. Peak bone mass is a significant
predictor of future osteoporosis and fracture risk; therefore, it is important to optimize peak
bone mass during young adulthood in both males and females.
Several recent longitudinal studies have found significant bone loss in young men and a
summary of the findings of these studies is shown in Box 1. Compiling the data from these
studies indicates that the early bone loss that has been reported is predominantly in trabecular
bone and is independent of sex hormone concentrations. Studies discussed previously indicate
that the early loss of trabecular bone is associated with decreases in activity levels and lean
mass, especially in former athletes. Whether changes in physical activity levels among
nonathletes leads to increased rates of bone loss among young men needs further investigation.
Early bone loss in cortical vBMD or aBMD at predominantly cortical bone sites does not appear
to be significant, and when it does occur it is associated with decreased sex hormone
concentrations.
Box 1
Summary of findings on bone loss in young men
Cortical volumetric bone mineral density
• Data are conflicting, there are reports of an increase in young men [54] as well as
no significant changes [56]
• Changes that do occur are related to changes in sex hormones [56]
Trabecular volumetric bone mineral density
• Significant decrease occurs in young men [54,56,69]
• Decrease is not explained by changes in sex hormones [56]
Spine areal bone mineral density
• Decrease in areal bone mineral density may be due to an increase in bone size with
no change in bone mineral content [57]
• Decrease occurred at all ages from 22 years and older and the change is not related
to sex hormones [55]
Hip areal bone mineral density
• Data are conflicting, with some studies showing an increase [55] and others
showing a decrease [58,69]
• Change is not related to sex hormones [55]
• Change varies depending upon previous and current activity level [58,59,69]
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Future perspective
It is becoming increasingly clear that the influence of different factors (i.e., lifestyle and
hormonal) on bone is site specific and that changes in one bone site do not necessarily translate
to changes at all bone sites. Over the next 5–10 years the role of lifestyle and hormonal factors
on influencing bone gain and bone loss throughout the life cycle, and the underlying
mechanisms for their influence, will be better understood. This will be possible, in part, owing
to advances in bone imaging techniques that will lead to a greater understanding of how these
factors influence bone geometry and volumetric density, along with the development of
relatively inexpensive high-throughput genotyping methods. It is likely that the influence of
lifestyle and hormonal factors on bone will vary by the age and genetic make-up of an
individual. Large-scale epidemiologic studies are needed to provide the data that will enable
investigators to test hypotheses that challenge the current paradigm on the pathogenesis of
osteoporosis.
Executive summary
Epidemiology
• Osteoporosis and related fractures occur more frequently in women, but overall
fracture-related mortality is greater in men.
Bone as a tissue
• Bone modeling leads to increases in bone size, while bone remodeling is important
for repairing microfractures and allowing for dynamic adaptation to variable
external stresses.
Methods of assessing bone
• Dual energy x-ray absorptiometry provides measures of areal bone mineral density
(aBMD), not volumetric BMD (vBMD); low aBMD Z scores are associated with
increased fracture risk.
• Quantitative computed tomography measures cortical and trabecular vBMD and
provides a 3D assessment of bone size and geometry.
Role of androgen & estrogen on male bone
• Circulating estrogen in men is derived from the aromatization of testicular-derived
androgens.
• Androgen and estrogen are important for bone growth and mineralization in the
male skeleton.
Peak bone mass in males
• Peak bone mass is thought to be achieved by the early-to-mid 20s.
• Rates of bone change based on cross-sectional and longitudinal studies may differ.
Role of body composition on bone in adolescent & young adult men
• Consistent findings of a beneficial effect of lean mass on bone have been reported.
• Findings on the effect of fat mass on bone are inconsistent, but tend to indicate an
adverse effect of fat mass on bone.
Longitudinal bone changes in young adult men
• Significant loss of aBMD at cortical bone sites begins in the mid 30s.
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• Increases in bone size due to periosteal expansion may explain why decreases in
aBMD among young men are observed without an apparent change in bone mineral
content.
Relationship of sex hormones to bone changes in young adult men
• Changes in cortical vBMD and aBMD at cortical bone sites are associated with
circulating concentrations of sex hormones.
• The higher rates of loss in trabecular vBMD or aBMD at trabecular bone sites (i.e.,
spine) among young versus old men are not associated with sex hormone
concentrations.
Relationship of lean mass or activity to longitudinal bone changes in young adult men
• Structural adaptations in bone occur with mechanical loading; these may vary by
bone site and differ in trabecular and cortical bone.
• Changes in lean mass and activity levels are important predictors of change in
aBMD at trabecular-rich bone sites in young men.
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Figure 1. Peripheral quantitative computed tomography image of the 4 and 20% distal radius
showing periosteal and endosteal circumferences and cortical and trabecular volumetric bone
mineral density
vBMD: Volumetric bone mineral density.
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Figure 2. Difference in rate of change estimation based on cross-sectional (A) and longitudinal (B)
data
Regression lines can be fitted to cross-sectional data and the rates of loss estimated based on
the regression equation (A), whereas longitudinal data allow for the calculation of actual rates
of change within an individual and mean rates of change can then be calculated (B). aBMD:
Areal bone mineral density.
Specker et al. Page 17
Int J Clin Rheumtol. Author manuscript; available in PMC 2011 February 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Percent change per year according to baseline age decade in men aged 20–100 years for
(A) trabecular volumetric bone mineral density, (B) total bone area and (C) cortical bone area
Data taken from [54].
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Figure 4. Unadjusted mean femoral neck areal bone mineral density in active athletes, former
athletes and controls
aBMD: Areal bone mineral density.
Data taken from [59].
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Figure 5.
Change in hip areal bone mineral density Z-scores (A) and areal bone mineral density over 3
years (B) in men known to play varsity sports while in college compared with age-matched
men whose sport status during college is unknown.
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e
6 
ye
ar
s (
0,
 3
 a
nd
 6
ye
ar
s)
11
73
 (5
40
 m
en
)
en
ro
lle
d;
 3
45
 m
en
 h
ad
ba
se
lin
e b
on
e m
ea
su
re
s
pQ
C
T 
4%
 ti
bi
a:
 to
ta
l a
nd
tra
be
cu
la
r v
B
M
D
; p
Q
C
T
38
%
 ti
bi
a:
 to
ta
l a
nd
co
rti
ca
l b
on
e 
ar
ea
,
m
ed
ul
la
ry
 a
re
a 
an
d 
C
SM
I
N
um
be
rs
 o
f m
en
w
ith
 3
- a
nd
 6
-y
ea
r
da
ta
 w
er
e 
no
t
gi
ve
n.
 T
ot
al
s (
m
en
an
d 
w
om
en
) w
er
e
92
6 
at
 3
 y
ea
rs
, a
nd
80
9 
at
 6
 y
ea
rs
Pe
rio
st
ea
l e
xp
an
si
on
 in
cr
ea
se
s i
n
yo
un
ge
r m
en
. T
hi
s, 
co
m
bi
ne
d 
w
ith
a 
si
m
ila
r m
ed
ul
la
ry
 e
xp
an
si
on
ac
ro
ss
 a
ll 
ag
es
, l
ea
ds
 to
 g
re
at
er
in
cr
ea
se
 in
 c
or
tic
al
 b
on
e 
ar
ea
am
on
g 
yo
un
ge
r m
en
 co
m
pa
re
d 
w
ith
ol
de
r m
en
. D
ec
re
as
e 
in
 tr
ab
ec
ul
ar
vB
M
D
 is
 g
re
at
er
 in
 y
ou
ng
er
 v
er
su
s
ol
de
r m
en
[5
4]
H
or
m
on
e-
re
la
te
d 
stu
di
es
K
ho
sl
a 
et
 a
l. 
(2
00
1)
A
ge
-s
tra
tif
ie
d 
ra
nd
om
,
po
pu
la
tio
n-
ba
se
d 
sa
m
pl
e 
of
m
en
 in
 R
oc
he
st
er
, M
N
,
U
SA
4 
ye
ar
s (
0,
 2
 a
nd
 4
ye
ar
s)
22
–3
9 
(3
1)
 y
ea
rs
 (n
 =
88
); 
40
–5
9 
(5
0)
 y
ea
rs
(n
 =
 9
7)
; 6
0–
90
 (7
4)
ye
ar
s (
n 
= 
13
0)
; t
ot
al
 n
= 
31
5 
(>
 o
ne
 v
is
it)
D
X
A
: s
pi
ne
, h
ip
 a
nd
 m
id
-
di
st
al
 ra
di
us
 a
B
M
D
In
te
re
st
ed
 in
re
la
tio
ns
hi
p
be
tw
ee
n 
se
x
st
er
oi
ds
 a
nd
lo
ng
itu
di
na
l b
on
e
ch
an
ge
s
D
ec
re
as
e 
in
 sp
in
e 
aB
M
D
 o
cc
ur
s a
t
al
l a
ge
s a
nd
 is
 n
ot
 re
la
te
d 
to
es
tro
ge
n 
or
 te
st
os
te
ro
ne
 le
ve
ls
.
In
cr
ea
se
 in
 h
ip
 a
nd
 ra
di
us
 a
B
M
D
w
er
e 
ob
se
rv
ed
 in
 y
ou
ng
er
 m
en
.
G
re
at
er
 in
cr
ea
se
 in
 ra
di
us
 a
B
M
D
,
bu
t n
ot
 h
ip
, w
er
e 
as
so
ci
at
ed
 w
ith
in
cr
ea
se
d 
se
ru
m
 e
st
ro
ge
n 
le
ve
ls
 in
yo
un
g 
m
en
[5
5]
R
ig
gs
 e
t a
l. 
(2
00
8)
A
ge
-s
tra
tif
ie
d 
ra
nd
om
,
po
pu
la
tio
n-
ba
se
d 
sa
m
pl
e 
of
m
en
 a
ge
d 
21
–9
7 
ye
ar
s i
n
R
oc
he
st
er
, M
N
, U
SA
3 
ye
ar
s (
an
nu
al
ly
fo
r r
ad
iu
s;
 b
as
el
in
e
an
d 
3 
ye
ar
s f
or
sp
in
e)
30
9 
m
en
 w
ith
 a
t l
ea
st
 1
an
d 
up
 to
 3
 y
ea
rs
 o
f
ra
di
al
 p
Q
C
T 
da
ta
; 2
60
m
en
 w
ith
 b
as
el
in
e 
an
d
3 
ye
ar
s s
pi
ne
 Q
C
T 
da
ta
Sp
ira
l Q
C
T 
an
d 
pQ
C
T:
sp
in
e 
an
d 
ra
di
us
tra
be
cu
la
r a
nd
 c
or
tic
al
vB
M
D
–
D
ec
re
as
e 
in
 tr
ab
ec
ul
ar
 v
B
M
D
ob
se
rv
ed
 in
 y
ou
ng
 m
en
 (3
0–
39
ye
ar
s)
 a
nd
 n
ot
 a
ss
oc
ia
te
d 
w
ith
ho
rm
on
e 
le
ve
ls
. R
at
e 
of
 c
ha
ng
e 
in
co
rti
ca
l v
B
M
D
 w
as
 a
ss
oc
ia
te
d 
w
ith
bi
oa
ct
iv
e 
E 2
, t
es
to
st
er
on
e 
an
d 
IG
F-
I (
hi
gh
er
 h
or
m
on
es
, l
ow
er
 ra
te
s o
f
lo
ss
). 
R
at
e 
of
 c
ha
ng
e 
in
 c
or
tic
al
vB
M
D
 in
 m
en
 y
ou
ng
er
 th
an
 4
0
ye
ar
s w
as
 n
ot
 d
iff
er
en
t f
ro
m
 0
[5
6]
Ac
tiv
ity
-r
el
at
ed
 st
ud
ie
s
B
ak
ke
r e
t a
l. 
(2
00
3)
Pa
rti
ci
pa
nt
s o
f t
he
A
m
st
er
da
m
 G
ro
w
th
 a
nd
H
ea
lth
 L
on
gi
tu
di
na
l S
tu
dy
(A
G
A
H
LS
; T
he
N
et
he
rla
nd
s)
10
 y
ea
rs
22
5 
m
en
 en
ro
lle
d 
at
 ag
e
13
 y
ea
rs
; b
on
e
m
ea
su
re
d a
t 2
7 (
n =
 84
),
32
 (n
 =
 1
95
) a
nd
 3
6 
(n
= 
17
0)
 y
ea
rs
 o
f a
ge
;
D
X
A
: s
pi
ne
 a
B
M
D
 a
nd
B
M
C
In
te
re
st
ed
 in
re
la
tio
ns
hi
p
be
tw
ee
n 
le
an
 m
as
s
an
d 
lo
ng
itu
di
na
l
bo
ne
 c
ha
ng
es
D
ec
re
as
e 
in
 sp
in
e 
aB
M
D
 b
et
w
ee
n
27
 a
nd
 3
2 
ye
ar
s o
f a
ge
. S
pi
ne
 B
M
C
di
d 
no
t c
ha
ng
e:
 a
B
M
D
 d
ec
re
as
e
be
tw
ee
n 2
7 a
nd
 32
 ye
ar
s m
ay
 be
 du
e
to
 in
cr
ea
se
 in
 b
on
e 
si
ze
. L
ea
n 
m
as
s
[5
7]
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St
ud
y
St
ud
y 
po
pu
la
tio
n
L
en
gt
h 
of
 fo
llo
w
-
up
 (m
ea
su
re
m
en
t
tim
es
)
N
um
be
r
B
on
e 
si
te
s m
ea
su
re
d
C
om
m
en
ts
Si
gn
ifi
ca
nt
 fi
nd
in
gs
R
ef
.
n 
= 
48
 w
ith
 2
7-
 a
nd
 3
2-
ye
ar
 v
is
its
; n
 =
 4
1 
w
ith
32
- a
nd
 3
6-
ye
ar
s v
is
its
w
as
 th
e 
m
os
t s
ig
ni
fic
an
t p
re
di
ct
or
of
 sp
in
e 
aB
M
D
 a
nd
 B
M
C
 (i
nc
re
as
e
in
 le
an
 m
as
s a
ss
oc
ia
te
d 
w
ith
in
cr
ea
se
d 
aB
M
D
 a
nd
 B
M
C
)
N
or
ds
tro
m
 e
t a
l.
(2
00
7)
M
al
es
 re
cr
ui
te
d 
fr
om
 tw
o
no
rth
er
n 
Sw
ed
is
h 
hi
gh
sc
ho
ol
s a
nd
 ic
e 
ho
ck
ey
 a
nd
ba
dm
in
to
n 
cl
ub
s
(v
ol
un
te
er
s, 
no
t p
op
ul
at
io
n
ba
se
d)
7.
7 
ye
ar
s (
ag
es
 1
7,
19
, 2
3 
an
d 
25
ye
ar
s)
11
6 
at
 1
7 
ye
ar
s;
 1
07
 a
t
19
 y
ea
rs
; 1
02
 a
t 2
5
ye
ar
s
D
X
A
: s
pi
ne
, f
em
or
al
 n
ec
k
an
d 
hi
p 
aB
M
D
, B
M
C
 a
nd
bo
ne
 a
re
a;
 sp
in
e 
an
d 
FN
B
M
A
D
M
ix
ed
 e
ff
ec
t
m
od
el
 in
cl
ud
in
g
ag
e,
 p
hy
si
ca
l
ac
tiv
ity
, h
ei
gh
t,
w
ei
gh
t a
nd
pu
be
rta
l s
ta
tu
s
D
ec
re
as
e 
in
 h
ip
 a
nd
 fe
m
or
al
 n
ec
k
aB
M
D
 a
fte
r 1
9 
ye
ar
s, 
w
hi
ch
pa
ra
lle
le
d 
B
M
C
 lo
ss
. P
hy
si
ca
l
ac
tiv
ity
 d
ec
re
as
e 
fr
om
 7
.1
 to
 4
.2
 h
vi
go
ro
us
/w
ee
k 
be
tw
ee
n 
17
 a
nd
 2
5
ye
ar
s o
f a
ge
. D
ec
re
as
e 
in
 a
ct
iv
ity
as
so
ci
at
ed
 w
ith
 g
re
at
er
 d
ec
re
as
e 
in
aB
M
D
 lo
ss
 a
t a
ll 
si
te
s
[5
8]
Te
rv
o 
et
 a
l. 
(2
00
8 
an
d
20
09
)
A
dd
iti
on
al
 fo
llo
w
-u
p
re
po
rts
 b
as
ed
 o
n 
th
e
po
pu
la
tio
n 
in
 th
e 
in
iti
al
re
po
rt 
by
 N
or
ds
tro
m
 e
t a
l.
12
 y
ea
rs
 (a
ge
s 1
7,
19
, 2
3,
 2
5 
an
d 
29
ye
ar
s)
11
6 
ag
ed
 1
7 
ye
ar
s;
 9
9
ag
ed
 2
9 
ye
ar
s
D
X
A
: s
pi
ne
, F
N
 a
nd
 to
ta
l
bo
dy
 a
B
M
D
–
C
at
eg
or
iz
ed
 m
en
 in
to
 fo
rm
er
at
hl
et
es
, a
ct
iv
e 
at
hl
et
es
 a
nd
co
nt
ro
ls
. D
ec
re
as
es
 in
 a
B
M
D
 w
er
e
in
cr
ea
se
d 
am
on
g 
fo
rm
er
 a
th
le
te
s
co
m
pa
re
d 
w
ith
 c
ur
re
nt
 a
th
le
te
s a
nd
co
nt
ro
ls
, a
nd
 p
ar
al
le
le
d 
ch
an
ge
s i
n
ac
tiv
ity
 le
ve
ls
, e
sp
ec
ia
lly
 a
t
tra
be
cu
la
r b
on
e 
si
te
s
[5
9,
68
]
aB
M
D
: A
re
al
 b
on
e 
m
in
er
al
 d
en
si
ty
; B
A
: B
on
e 
ar
ea
; B
M
A
D
: B
on
e 
m
in
er
al
 a
pp
ar
en
t d
en
si
ty
; B
M
C
: B
on
e 
m
in
er
al
 c
on
te
nt
; C
SM
I: 
C
ro
ss
-s
ec
tio
na
l m
om
en
t o
f i
ne
rti
a;
 D
X
A
: D
ua
l e
ne
rg
y 
x-
ra
y 
ab
so
rp
tio
m
et
ry
;
E 2
: E
st
ra
di
ol
; F
FM
: F
at
 fr
ee
 m
as
s;
 F
N
: F
em
or
al
 n
ec
k;
 n
: N
um
be
r o
f i
nd
iv
id
ua
ls
; p
Q
C
T:
 P
er
ip
he
ra
l q
ua
nt
ita
tiv
e 
co
m
pu
te
d 
to
m
og
ra
ph
y;
 Q
C
T:
 Q
ua
nt
ita
tiv
e 
co
m
pu
te
d 
to
m
og
ra
ph
y;
 T
B
: T
ot
al
 b
od
y;
 v
B
M
D
:
V
ol
um
et
ric
 b
on
e 
m
in
er
al
 d
en
si
ty
.
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